Is Marrone Bio Innovations still a public company?

No. It stopped being independent in July 2022 when Bioceres Crop Solutions completed a ~$207M all-stock merger and renamed it Pro Farm Group. Pro Farm was then seized in a UCC foreclosure auction and sold to PFG Holding Corp for $15M, closing February 18, 2026.

Who owns Marrone Bio Innovations now?

PFG Holding Corporation, majority owned by Jasper Lake Ventures One LLC under Noah Kolatch, won Pro Farm Group's assets via a $15M credit bid at a noteholder foreclosure auction on January 20, 2026, with the deal closing around February 18, 2026.

Could AI replace Marrone Bio Innovations' biopesticide products?

Unlikely to directly replace them. EPA registration and field-agronomy work are largely AI-resistant, though AI-assisted microbe discovery could speed rival R&D, as seen when BASF announced its AgBiTech bioinsecticide acquisition in January 2026.

Is Marrone Bio Innovations profitable?

No standalone financials exist since the 2022 Bioceres merger. Parent Bioceres reported FY2025 revenue of ~$335M, down 28% year over year, and disclosed going-concern doubts in its fiscal Q2 FY26 SEC filing on March 17, 2026.

Who is Marrone Bio Innovations' biggest competitor?

Certis Biologicals and Valent BioSciences are close biologicals peers, while giants like BASF, which announced acquiring AgBiTech in January 2026, plus Bayer and Corteva, are all now consolidating the biopesticide category.

What happened to Marrone Bio Innovations' assets in 2026?

Noteholders forced a UCC foreclosure auction on January 20, 2026, after Pro Farm Group defaulted on secured notes. PFG Holding Corp won the assets with a $15M credit bid against a roughly $194M carrying value, closing February 18, 2026.

Food tech and alternative protein · subsidiary of PFG Holding Corporation (Jasper Lake Ventures One LLC majority owner) · United States

Marrone Bio Innovations

marronebio.com ↗

Biopesticide brand now owned by a private buyer after a $15M foreclosure sale.

Little protection left

Assessed 25 July 2026 · Evidence as of 25 July 2026

Not much stands between this business and its pressures.

On the recordSince 25 July 2026 · Checkable from Sept 14, 2026 · Every call on the record Checkpoint: Bioceres Nasdaq delisting compliance deadline (possible 180 day extension)

The call

The products now sit inside a four month old private holding company with no disclosed financing and an active lawsuit over who actually owns them.

Marrone Bio Innovations makes natural pest controls and soil treatments for crops, but the company was bought in 2022, went bankrupt, and was auctioned off for $15 million in early 2026 even though it was worth $194 million on paper. The new owner, ProFarm Group, is only four months old, has no public financial information, and is fighting in court over who actually owns what. The biggest threat is not new technology or AI, but whether the company can keep its farm customers and stay alive long enough to resolve the lawsuits, which won't be clear until late 2026.

Why

AI pressure: None apparent. AI can speed up microbe discovery for rivals, but it cannot replace field trials, EPA approval, or the current legal mess. Could AI do the core job? Unlikely.

Bigger players: Bayer, BASF, Corteva, Syngenta, FMC (biologicals consolidation). Big ag chemical companies keep buying biologicals rivals like BASF's AgBiTech deal, closing in on the space this brand once led. Could a giant copy it? Yes, easily.

What protects it. EPA-registered products and patents from the 2022 merger still carry value if the ownership fight ever resolves cleanly.

What would change this call

PFG Holding Corp discloses (or fails to disclose) a standalone capitalization plan and balance-sheet financials. Shows whether the post-foreclosure entity has real funding to operate, not just seized assets.
Outcome of Bioceres/noteholder litigation damages phase (pending as of June 2026). Determines whether title to Pro Farm assets and financial exposure remain unresolved.
Distributor and customer retention data through the FY26 growing season. Indicates whether farmers and distributors are sticking with the brand through ownership chaos.

Key numbers

$15M paid for assets carried at ~$194M (2026-01-20)
Bioceres FY2025 revenue fell 28% to ~$335M (2025-09-08)
Q3 FY26 continuing revenue down 23% to $39.4M (2026-06-01)

Named risks

Bioceres litigation over Pro Farm foreclosure remains unresolved with damages phase pending as of June 2026. Severity: high
No disclosed standalone capitalization or balance-sheet financials for PFG Holding Corp since Feb 2026 closing. Severity: high
Parent Bioceres faces Nasdaq delisting if bid price noncompliance persists past September 14, 2026. Severity: medium
Bioceres disclosed going-concern doubts in its fiscal Q2 FY26 SEC filing, March 2026. Severity: high
Sector consolidation by BASF, Bayer, Corteva increases competitive pressure on a distressed standalone entity. Severity: medium

Rivals, as read in July 2026

Rival	Direction	Evidence
BASF	gaining on	Announced acquisition of biologicals rival AgBiTech in January 2026
Bayer, Corteva, Syngenta, FMC	gaining on	All directly investing in biologicals platforms as of March 2026, per industry coverage
Certis Biologicals	contesting	Direct biologicals peer, absorbed AgBiome fungicide assets in December 2024

Questions people ask

Is Marrone Bio Innovations still a public company?: No. It stopped being independent in July 2022 when Bioceres Crop Solutions completed a ~$207M all-stock merger and renamed it Pro Farm Group. Pro Farm was then seized in a UCC foreclosure auction and sold to PFG Holding Corp for $15M, closing February 18, 2026.
Who owns Marrone Bio Innovations now?: PFG Holding Corporation, majority owned by Jasper Lake Ventures One LLC under Noah Kolatch, won Pro Farm Group's assets via a $15M credit bid at a noteholder foreclosure auction on January 20, 2026, with the deal closing around February 18, 2026.
Could AI replace Marrone Bio Innovations' biopesticide products?: Unlikely to directly replace them. EPA registration and field-agronomy work are largely AI-resistant, though AI-assisted microbe discovery could speed rival R&D, as seen when BASF announced its AgBiTech bioinsecticide acquisition in January 2026.
Is Marrone Bio Innovations profitable?: No standalone financials exist since the 2022 Bioceres merger. Parent Bioceres reported FY2025 revenue of ~$335M, down 28% year over year, and disclosed going-concern doubts in its fiscal Q2 FY26 SEC filing on March 17, 2026.
Who is Marrone Bio Innovations' biggest competitor?: Certis Biologicals and Valent BioSciences are close biologicals peers, while giants like BASF, which announced acquiring AgBiTech in January 2026, plus Bayer and Corteva, are all now consolidating the biopesticide category.
What happened to Marrone Bio Innovations' assets in 2026?: Noteholders forced a UCC foreclosure auction on January 20, 2026, after Pro Farm Group defaulted on secured notes. PFG Holding Corp won the assets with a $15M credit bid against a roughly $194M carrying value, closing February 18, 2026.

Timeline

2026-06-22NY court grants noteholders partial summary judgment against Bioceres; damages phase pending
2026-03-17Nasdaq notifies Bioceres of bid-price noncompliance; deadline Sept 14, 2026
2026-03-16Bioceres CEO says Pro Farm foreclosure not yet formally concluded
2026-02-18PFG Holding Corp closes acquisition of Pro Farm Group assets
2026-01-20UCC foreclosure auction; PFG Holding wins Pro Farm assets for $15M credit bid
2025-09-08Bioceres reports FY2025 revenue ~$335M, down 28% YoY
2022-07-12Bioceres completes merger with Marrone Bio, renaming it Pro Farm Group
2013Marrone Bio Innovations IPOs on Nasdaq as MBII, raising $57M

Revision history

25 July 2026

First assessed. Little protection left. The text above is fixed as of this date and is not edited afterwards.

In the same band

Aspire Food Group AgEagle Aerial Systems Beyond Meat

More in Food tech and alternative protein →

Sources